Results 171 to 180 of about 92,879 (297)

Intentions and attitudes of caregivers towards enrolment of their children and adolescents living with HIV into remission trials involving analytic treatment interruption

Journal of the International AIDS Society, Volume 29, Issue 2, February 2026.
Abstract Introduction The development of approaches and interventions to achieve HIV remission continues to accelerate. Children living with HIV who started antiretroviral therapy (ART) at a young age and sustain viral suppression are an ideal clinical trial population. Trials may require analytic treatment interruptions (ATIs).
Holly L. Peay, Kennedy Otwombe, Shaun Barnabas, Ana Barrios‐Tascon, Maria Grazia Lain, Tacilta Nhampossa, Diana Rutebarika, Thidarat Jupimai, Moherndran Archary, Almoustapha‐Issiaka Maiga, Avy Violari, Moira J. Spyer, Kavidha Reddy, Paolo Palma, Savita Pahwa, Mathias Lichterfeld, Mark Cotton, Louise Kuhn   +17 more
wiley   +1 more source

mRNA vaccines for HBV: Mechanisms, preclinical advances, and therapeutic clinical progress. [PDF]

Mol Ther Nucleic Acids
Pechnikova NA, Zafeiriou-Chatziefraimidou M, Poimenidou M, Patsidou C, Iliadis I, Ostankova YV, Yaremenko AV.   +6 more
europepmc   +1 more source

Construction of Reverse Genetics System for Feline Calicivirus FCV‐BJ616 and Proteomic Analysis

MicrobiologyOpen, Volume 15, Issue 1, February 2026.
This study successfully isolated the FCV‐BJ616 strain derived from cats and established a reverse genetics system. In vivo experiments showed that rFCV‐BJ616 exhibits wild‐type virulence, leading to high fever, weight loss, and multi‐organ lesions in infected cats. Proteomic analysis indicated that both rFCV‐BJ616 and FCV‐BJ616 share similar regulatory
Chunmei Xu, Jingjie Zhao, Hao Liu, Haotian Gu, Xinming Tang, Lin Liang, Jiabo Ding, Shaohua Hou, Xiaomin Zhao, Ruiying Liang   +9 more
wiley   +1 more source

The Role of MASP1, MASP2, and Mannose-Binding Lectin in the Immune Response to Hepatitis B Vaccination in Infants. [PDF]

Vaccines (Basel)
Tapcı AE, Bulut İ, Taşar S, Kallimci Z, Yetkin KÇ, Sevim M, Serin O, Taşar MA, Şenes M, Alioğlu B.   +9 more
europepmc   +1 more source

Response to Comments on 'Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines'. [PDF]

J Viral Hepat
Journal of Viral Hepatitis, Volume 33, Issue 2, February 2026.
Campbell C, Wang T, Barnes E, Matthews PC, UK Health Informatics Collaborative for Viral Hepatitis and Liver Disease.   +4 more
europepmc   +2 more sources

Tumor Immunotherapy and Microbiome: From Bench‐to‐Bedside Applications

MedComm, Volume 7, Issue 2, February 2026.
The microbiome is related to the efficacy of immunotherapy and can be utilized to predict the efficacy and adverse reactions of immunotherapy. Microbiome‐targeted intervention strategies can improve the efficacy of ICI, but necessitating more comprehensive exploration.
Anqi Lin, Minying Xiong, Aimin Jiang, Li Chen, Lihaoyun Huang, Kailai Li, Hank Z. H. Wong, Jian Zhang, Zaoqu Liu, Quan Cheng, Bufu Tang, Pengpeng Zhang, Peng Luo   +12 more
wiley   +1 more source

Yeast-Based Vaccine Platforms: Applications and Key Insights from the COVID-19 Era. [PDF]

Biomolecules
Baindara P, Dinata R, Kumar R.
europepmc   +1 more source

Neuro‐Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets

MedComm, Volume 7, Issue 2, February 2026.
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo, Hui Liu, Yu‐Jing Song, Jian‐Hua Wang, Danfeng Liu, Zhi‐Wei Zheng, Jia‐Jun Li, Boya Li, An Song, Wei He, Lei‐Lei Yang, Shuo Wang   +11 more
wiley   +1 more source

A review of vaccinology and <i>ex vivo</i> antigen-loaded dendritic cells: A different approach to infectious disease vaccines. [PDF]

Hum Vaccin Immunother
Dillman RO, Nistor GI, Keirstead HS.
europepmc   +1 more source

State‐of‐the‐Art Strategies for Circular RNA in Cancers: Opportunity and Challenge

MedComm, Volume 7, Issue 2, February 2026.
Overview of circular RNA in tumors. ABSTRACT Circular RNAs (circRNAs) are characterized by their covalently closed structure, remarkable stability, and precise spatiotemporal regulation, evolving from once‐overlooked transcriptional byproducts to pivotal molecular regulators.
Zehao Ding, Zai Luo, Liao Zhang, Shaopeng Zhang, Renchao Zhang, Zhengjun Qiu, Chen Huang   +6 more
wiley   +1 more source